Clinical Trial Update: Evaluating Cannabidiol as a Novel Anticraving Medication for Alcohol Use Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial is evaluating cannabidiol as an anticraving medication for Alcohol Use Disorder; recruitment is ongoing. Sponsored by the Centre for Addi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Alcohol Use Disorder | Phase 2 | Status: RECRUITING